SC0191 Plus Chemotherapy in Advanced Ovarian Canceradvanced Ovarian Cancer
Status:
Not yet recruiting
Trial end date:
2025-11-30
Target enrollment:
Participant gender:
Summary
A phase Ib/II clinical study on the safety, pharmacokinetic characteristics, and preliminary
efficacy of SC0191 combination chemotherapy in patients with advanced ovarian cancer.